GW788388 10mg 10mg | Purity Not Available
Adooq Bioscience
GW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageTG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic activity.
More Information Supplier PageCCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.
More Information Supplier PageCCT137690 is a potent inhibitor of Aurora kinases that inhibits Aurora A and B kinases with low nanomolar IC50 values in both biochemical and cellular assays.
More Information Supplier PagePH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase.
More Information Supplier PageJTC-801 is a selective antagonist for the nociceptin receptor, also known as the ORL-1 receptor.
More Information Supplier Page